Saiba AG Selects AGC Biologics to Develop and Produce COVID-19 Vaccine.
AGC Biologics will manufacture SARS-CoV-2 vaccine for partner Saiba AG.
The company currently employs more than 1000 employees worldwide. AGC Biologics’ global network spans three continents, with cGMP-compliant facilities in Seattle, Washington; Boulder, Colorado; Copenhagen, Denmark; Heidelberg, Germany; and Chiba, Japan.
Molecular Medicine SpA (MolMed) is a medical biotechnology company. The Company is focused on discovery, R&D, and clinical validation of innovative therapies for the treatment of cancer.
a company with shares listed on the Italian Stock Exchange (Milan)
Market Summary > Molecular Medicine SpA BIT: MLM 0.50 EUR